INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 95 filers reported holding INSTIL BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,517,504 | -22.3% | 8,218,467 | 0.0% | 1.92% | +111.6% |
| Q2 2023 | $4,528,375 | -16.6% | 8,218,467 | 0.0% | 0.91% | -17.0% |
| Q1 2023 | $5,430,763 | +4.9% | 8,218,467 | 0.0% | 1.10% | -15.8% |
| Q4 2022 | $5,177,634 | -87.0% | 8,218,467 | 0.0% | 1.30% | -83.3% |
| Q3 2022 | $39,777,000 | +4.8% | 8,218,467 | 0.0% | 7.80% | +2.3% |
| Q2 2022 | $37,969,000 | -57.0% | 8,218,467 | 0.0% | 7.63% | -48.5% |
| Q1 2022 | $88,349,000 | -39.1% | 8,218,467 | -3.1% | 14.82% | -44.6% |
| Q4 2021 | $145,072,000 | -4.3% | 8,478,790 | 0.0% | 26.75% | +60.1% |
| Q3 2021 | $151,558,000 | -7.5% | 8,478,790 | 0.0% | 16.71% | -38.3% |
| Q2 2021 | $163,810,000 | -23.0% | 8,478,790 | 0.0% | 27.08% | -33.4% |
| Q1 2021 | $212,648,000 | – | 8,478,790 | – | 40.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |